Interpretation of Thrombosis Prevention Trial

Lancet. 1998 Apr 18;351(9110):1205-6; author reply 1206-7. doi: 10.1016/S0140-6736(05)79153-4.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Coronary Thrombosis / mortality
  • Coronary Thrombosis / prevention & control*
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Humans
  • Male
  • Myocardial Ischemia / mortality
  • Myocardial Ischemia / prevention & control*
  • Risk Factors
  • Survival Rate
  • Warfarin / administration & dosage*
  • Warfarin / adverse effects

Substances

  • Anticoagulants
  • Warfarin
  • Aspirin